Farther Finance Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$168K Sell
8,530
-8,774
-51% -$180K ﹤0.01% 2444
2026
Q2
$338K Buy
17,304
+14,722
+570% +$292K ﹤0.01% 1865
2026
Q1
$50.3K Sell
2,582
-3,106
-55% -$61.2K ﹤0.01% 2990
2025
Q4
$108K Buy
5,688
+1,736
+44% +$32.2K ﹤0.01% 2306
2025
Q3
$73.7K Buy
3,952
+3,449
+686% +$64.4K ﹤0.01% 2223
2025
Q2
$9.27K Buy
503
+139
+38% +$2.47K ﹤0.01% 3114
2025
Q1
$6.37K Buy
364
+27
+8% +$455 ﹤0.01% 2942
2024
Q4
$5.84K Sell
337
-93
-22% -$1.7K ﹤0.01% 2601
2024
Q3
$7.99K Buy
430
+43
+11% +$725 ﹤0.01% 2455
2024
Q2
$5.96K Buy
387
+175
+83% +$2.5K ﹤0.01% 2320
2024
Q1
$3.12K Sell
212
-662
-76% -$9.17K ﹤0.01% 2298
2023
Q4
$12.5K Buy
874
+207
+31% +$2.94K ﹤0.01% 1520
2023
Q3
$9.3K Buy
+667
New +$8.53K ﹤0.01% 1309

Other funds holding SBRA

Farther Finance Advisors's SBRA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Sabra Healthcare REIT (SBRA) stake by 51% in Q3 2026, selling an estimated $180K and leaving 8,530 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2444.

Farther Finance Advisors first reported a position in SBRA in Q3 2023 and has held it in 13 quarters since. The position peaked at $338K in Q2 2026. 17 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Farther Finance Advisors held 8,530 shares of Sabra Healthcare REIT worth $168K as of Q3 2026.
  • Farther Finance Advisors sold 8,774 Sabra Healthcare REIT shares in Q3 2026, an estimated $180K.
  • Sabra Healthcare REIT made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2444 holding.
  • Farther Finance Advisors first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 13 quarters since.
  • Farther Finance Advisors's Sabra Healthcare REIT position peaked at $338K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.